VicenteValeroMD

Clinical Trials

• Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine Start of enrollment: 2007 May 23

  Completed

• Exemestane-RAD001-Metformin Start of enrollment: 2012 Sep 01

  Terminated

  Phase 2

• T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Start of enrollment: 2013 May 01

  Active, not recruiting

  Phase 2

• M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer Start of enrollment: 2018 May 30

  Terminated

  Phase 1

  Roles: Contact, Principal Investigator

• Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer Start of enrollment: 2017 Aug 11

  Active, not recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) Start of enrollment: 2021 Nov 16

  Active, not recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer Start of enrollment: 2007 Apr 17

  Recruiting

  Roles: Contact, Principal Investigator

• ATEMPT 2.0: Adjuvant T-DM1 vs TH Start of enrollment: 2021 Jun 16

  Recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• Join now to see all